Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.16%17.63B | 24.41%4.57B | 34.05%4.93B | 27.97%15.05B | 21.31%3.99B | 29.58%3.7B | 17.42%3.68B | 48.27%3.68B | 35.15%11.76B | 42.35%3.29B |
| Cost of revenue | 18.46%15.44B | 25.03%3.94B | 34.39%4.21B | 25.65%13.03B | 18.91%3.4B | 32.60%3.34B | 17.02%3.15B | 36.54%3.14B | 31.35%10.37B | 39.14%2.86B |
| Gross profit | 8.76%2.19B | 20.64%629.19M | 32.13%718.79M | 45.34%2.02B | 37.18%594.18M | 6.74%356.22M | 19.91%521.56M | 193.66%543.98M | 72.47%1.39B | 67.96%433.13M |
| Operating expense | 8.20%1.7B | 2.67%416.57M | 18.37%441.79M | 28.48%1.57B | 29.54%458.52M | 17.69%336.7M | 28.18%405.74M | 38.93%373.23M | 14.28%1.23B | 37.05%353.97M |
| Operating profit | 10.76%489.25M | 83.59%212.62M | 62.22%277M | 173.00%441.74M | 71.37%135.66M | -59.03%19.51M | -2.21%115.82M | 304.73%170.76M | 160.40%161.81M | 20,294.39%79.16M |
| Net non-operating interest income (expenses) | -25.09%-160.15M | -27.64%-40.53M | -14.92%-36.69M | -18.31%-128.02M | -6.33%-31.82M | -25.49%-32.52M | -22.93%-31.75M | -20.33%-31.93M | -0.80%-108.21M | -15.55%-29.93M |
| Non-operating interest income | -90.00%1K | --0 | --0 | 100.00%10K | 0.00%1K | 700.00%8K | -66.67%1K | --0 | -99.80%5K | -99.82%1K |
| Non-operating interest expense | 25.08%160.15M | 27.63%40.53M | 14.92%36.69M | 18.32%128.03M | 6.33%31.83M | 25.52%32.52M | 22.92%31.76M | 20.33%31.93M | -1.47%108.21M | 13.14%29.93M |
| Net investment income | -151.79%-21.51M | -236.30%-25.02M | -37.97%9.48M | -23.09%41.52M | -1,360.63%-5.64M | -1.35%13.52M | 46.05%18.36M | -43.95%15.28M | 272.42%53.99M | -88.53%447K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 9.17M | 0 | 0 | 40.04M | 0 | |||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 97.02%-3.63M | 5.84%-741K | 355.17%518K | -125,261.86%-121.6M | -57,960.87%-119.77M | -839K | 91.50%-787K | -102.27%-203K | -100.16%-97K | 128.51%207K |
| Less:Other special charges | 187.51%3.63M | -5.84%741K | -355.17%-518K | -4,374.23%-4.15M | -2,786.47%-5.98M | --839K | -91.50%787K | 102.27%203K | 100.16%97K | -128.51%-207K |
| Less:Write off | --0 | ---- | ---- | --125.75M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | 13.58%59.74M | 50.33%14.76M | 122.58%12.76M | 29.02%52.6M | 7.57%28.85M | -19.23%8.2M | -24.06%9.82M | 162.76%5.73M | -78.51%40.77M | -41.57%26.82M |
| Income before tax | 30.27%372.88M | 44.54%161.09M | 64.79%263.06M | 52.01%286.24M | -90.51%7.28M | -82.72%7.87M | 2.40%111.45M | 472.84%159.64M | 268.57%188.3M | 236.78%76.7M |
| Income tax | 239.96%156.58M | 60.96%54.67M | 484.38%116.61M | -92.90%-111.88M | -83.37%-133.93M | -232.30%-31.86M | 448.51%33.96M | 231.00%19.95M | -661.40%-58M | -505.36%-73.04M |
| Net income | -45.67%216.3M | 37.35%106.43M | 4.85%146.45M | 61.64%398.11M | -5.70%141.21M | 84.96%39.74M | -24.52%77.48M | 606.38%139.68M | 301.83%246.3M | 3,048.59%149.75M |
| Net income continuous operations | -45.67%216.3M | 37.35%106.42M | 4.85%146.46M | 61.64%398.11M | -5.70%141.21M | 84.94%39.74M | -24.51%77.48M | 606.38%139.69M | 301.83%246.29M | 3,047.89%149.75M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -45.67%216.3M | 37.35%106.43M | 4.85%146.45M | 61.64%398.11M | -5.70%141.21M | 84.96%39.74M | -24.52%77.48M | 606.38%139.68M | 301.83%246.3M | 3,048.59%149.75M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -45.67%216.3M | 37.35%106.43M | 4.85%146.45M | 61.64%398.11M | -5.70%141.21M | 84.96%39.74M | -24.52%77.48M | 606.38%139.68M | 301.83%246.3M | 3,048.59%149.75M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -45.67%103.21 | 37.35%50.78 | 4.85%69.88 | 61.64%189.96 | -5.70%67.38 | 84.98%18.96 | -24.52%36.97 | 606.46%66.65 | 301.82%117.52 | 3,061.50%71.45 |
| Diluted earnings per share | -45.67%103.21 | 37.35%50.78 | 4.85%69.88 | 61.64%189.96 | -5.70%67.3778 | 84.98%18.96 | -24.52%36.97 | 606.46%66.65 | 301.82%117.52 | 3,061.50%71.45 |
| Dividend per share | 0.00%20 | 0 | 0 | 20 | 20 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |